Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA)

12.86
Delayed Data
As of Aug 09
 -0.09 / -0.69%
Today’s Change
7.36
Today|||52-Week Range
15.25
+9.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
AssetsCash56.1M45.7M72.0M--
 
 
 
 
Short Term Investment Cash20.6M-10.4M26.5M--
 
 
 
 
Cash & Short Term Investments56.1M45.7M307.3M--
 
 
 
 
 
ReceivablesReceivables0.000.000.00----
 
InventoriesInventories0.000.000.00----
 
Current AssetsOther Current Assets259.0K1.4M6.4M--
 
 
 
 
Current Assets56.3M47.1M313.8M--
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross108.0K177.0K6.7M--
 
 
 
 
Depreciation-24.0K-52.0K-319.0K--
 
 
 
 
Other Assets8.0K25.0K433.0K--
 
 
 
 
Total Assets56.5M47.5M322.0M--
 
 
 
 
 
LiabilitiesAccounts Payable212.0K1.2M10.9M--
 
 
 
 
Accrued Expenses1.1M14.6M25.7M--
 
 
 
 
Other Current Liabilities1.1M14.6M26.0M--
 
 
 
 
Other Liabilities2.3M17.4M42.6M--
 
 
 
 
 
Total LiabilitiesDeferred Taxes-41.0K-238.0K-1.2M--
 
 
 
 
Other Liabilities0.000.00144.0K--
 
 
Total Liabilities2.3M17.4M42.7M--
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock79.9M119.8M0.00--
 
 
 
Common Equity-25.7M-89.7M279.3M--
 
 
 
 
Total Shareholder Equity54.2M30.1M279.3M--
 
 
 
 
 
Share InformationCommon Shares Outstanding49.7M49.7M49.5M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.